S159: QUÉBEC CML RESEARCH GROUP ANALYSIS OF TREATMENT PATTERNS IN CHRONIC MYELOGENOUS LEUKEMIA: SWITCHING IS DRIVEN BY INTOLERANCE AND SIMILAR ACROSS TYROSINE KINASE INHIBITORS AND... by L. Busque, M. Harnois, N. Szuber, R. Delage, L. Mollica, H. Olney, P. Laneuville, S. Sirhan, G. Cournoyer, I. Chamakhi, M. Lalancette, D. Talbot, V. Éthier, P. Desjardins, S. Assouline

Get full text

S158: FINAL RESULT OF TKI DISCONTINUATION TRIAL WITH DASATINIB FOR SECOND ATTEMPT OF TREATMENT FREE REMISSION AFTER FAILING FIRST ATTEMPT WITH IMATINIB: TREATMENT-FREE REMISSION AC... by D. Kim, E. Atenafu, D. Forrest, I. Bence-Bruckler, L. Savoie, M.-M. Keating, L. Busque, R. Delage, A. Xenocostas, E. Liew, P. Laneuville, K. Paulson, T. Stockley, J. Lipton, B. Leber

Get full text

P708: CANADIAN AND RUSSIAN EXPERIENCES OF ASCIMINIB IN CHRONIC MYELOID LEUKEMIA (CML) PATIENTS WHO FAILED MULTIPLE LINES OF TYROSINE KINASE INHIBITOR (TKI) THERAPY. by F. Khadadah, A. G. Turkina, E. Lomaia, E. V. Morozova, O. A. Shukhov, A. Petrova, T. Chitanava, J. J. Vlasova, E. Kuzmina, I. Nemchenko, E. Y. Chelysheva, A. Bykova, M. Gurianova, A. Xenocostas, L. Busque, K. Jamani, S. Cerquozzi, P. Kuruvilla, R. Kaedbey, B. Leber, S. Assouline, D. D. H. Kim

Get full text